Hypoxia-induced mitogenic factor (HIMF), also called FIZZ1 or RE-LM␣, was a newly found cytokine. Hypoxia caused robust HIMF induction in the lung, and HIMF has potent pulmonary vasoconstrictive, proliferative, and angiogenic properties. To investigate the role of HIMF in lung development, we determined its spatial and temporal expression. Recently, we discovered the preeminent role of a hypoxiainduced mitogenic factor (HIMF) and member of the resistin family of proteins (1, 2), in the functional and structural response to chronic hypoxia in the adult murine lung (3). Apart from adipose tissue and spleen, HIMF was exclusively expressed in the lung, where it was detected in bronchial epithelial cells, type II alveolar cells, and endothelial cells. HIMF increased pulmonary arterial pressure and vascular resistance more potently than either endothelin-1 or angiotensin II and had potent proliferative and angiogenic properties. Because the role of HIMF in lung development has not been investigated in the past, we designed this study to explore the temporal and spatial expression of HIMF in embryonic mouse lung development.
cells differentiate; and (iv) alveolar stage (P5-P30), terminal sacs develop into mature alveolar ducts and alveoli (4) .
Angiogenesis, proliferation, and apoptosis are integral parts of adaptation and plasticity, for example in the response to hypoxia (5) . In embryonic lung, apoptosis is involved in lung remodeling and maturation in the saccular and alveolar stages (6) . Prenatally, mesenchymal cells have been shown to undergo apoptosis, presumably as a mechanism to thin the septa and establish an adequate pulmonary alveolar-capillary interface (7) . Because the effect of HIMF on apoptosis is not known, we investigated the presence of apoptosis in lung explant cultures treated with HIMF. Apoptotic cells in the lung were identified in situ using terminal deoxyribonucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick-end labeling (TUNEL).
HIMF had been shown to be upregulated by chronic hypoxia in vivo. Consistent with this observation was the finding, that the 3Ј region of the gene contains a binding site for the hypoxiainducible transcription factor (HIF)-1 and HIF-2 (3). Oxygen regulated gene expression as well as hypoxia signaling via HIFs has been shown to play an important role in embryonic development (8, 9) .
To elucidate the role of HIMF in embryonic lung development, we examined the temporal and spatial expression of HIMF during different stages of lung development and in relation to the expression of the hypoxia-inducible transcription factors HIF-1␣ and HIF-2␣. We found that HIMF is specifically upregulated in the saccular and alveolar stages in bronchial epithelial cells and type II alveolar cells. While searching for the presence of HIFs we observed that HIF-1␣ expression was temporally clearly distinct from HIMF expression. In contrast, HIF-2␣ was temporally and spatially coexpressed with HIMF. In addition, functional data provided evidence that HIMF has antiapoptotic properties ex vivo.
Materials and Methods

Animals
Timed pregnant C57Bl/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME). Mice were killed by halothane overdose; the abdominal cavity and uterus were opened, and embryos were harvested for study. Lungs from mice aged P1-P40 were obtained similarly. All experiments were approved by the Animal Care and Use Committee of Johns Hopkins University.
Northern Blot
Embryonic, neonatal and adult lung total RNA was extracted with TriReagent (Molecular Research Center, Cincinnati, OH) according to manufacturer's instructions. Fifteen micrograms of total RNA from E14, E15, E16, E17, E20, P1, P3, and adult lung was separated in 1% agarose gel. After RNA was transferred to nylon membrane overnight, the hybridization was performed at 45ЊC with 32 P-labeled HIMF cDNA. The membrane was washed with 2 ϫ saline sodium citrate (SSC), 0.1% sodium dodecylsulfate (SDS) at 45ЊC followed by 0.2 ϫ SSC, 0.1% SDS at 55ЊC. The membrane was exposed to a phosphoimager screen, and the signal was detected with a Storm Phosphoimager (Molecular Dynamics, Sunnyvale, CA). Ethidium bromide-stained 18 s and 28 s RNA was used as loading control.
Western Blot
The embryonic and postnatal mouse lung tissue collection and homogenization were performed as described before (10) . In brief, protein extracts were separated on a 4-20% polyacrylamide precast gel (BioRad, Hercules, CA) and transferred to nitrocellulose membranes. Immunodetection was performed using the following antibodies: HIMF antibody (1:1,000, produced as before [3] ), HIF-1␣ (1:500, Novus Biologicals, Littleton, CO), HIF-2␣ (1:1,000; Novus), and ␣-tubulin (1:1,000; Santa Cruz, Santa Cruz, CA), which was used as loading control. Incubation with primary antibody was followed by incubation with a 1:3,000 dilution of goat anti-rabbit or goat anti-mouse horseradish peroxidase (HRP)-labeled antibody (Bio-Rad) and visualization with ECL (Amersham Biosciences, Buckinghamshire, UK).
In Situ Hybridization
Synthetic fragments of sense and anti-sense oligonucleotides for HIMF were used as probes. The sequences were: sense 5Ј-gactctctcttgcactagtgtca-3; antisense: 5Ј-ttgacactagtgcaagagagagtc-3Ј. Both of oligoprobes were labeled with 6-Fam. Tissues were treated as described below in Histology. After deparaffinization, the slides were treated with 1ug/ml proteinase K in 100 mM tris, pH 8.0, and 50 mM EDTA for 15 min and were fixed in 2% paraformaldehyde for 5 min at room temperature. Sense and antisense probes (500 ng/ml) were added separately in the hybridization buffer (50% formamide, 4 ϫ SSC, 100 g/ml salmon sperm DNA, and 1 ϫ Denhardt's solution) and were incubated overnight at 45ЊC. After being washed with 2 ϫ SSC, 0.1% SDS at 45ЊC and 0.2 ϫ SSC, 0.1% SDS at 55ЊC, the slides were examined under an Olympus florescent microscope (Olympus, Tokyo, Japan).
TUNEL Labeling
The TUNEL method was performed according to the manufacturer's instructions (Roche, Indianapolis, IN). Briefly, after 24 h incubation with or without recombinant HIMF, the E13.5 and E16 embryonic lungs form different pregnancies (n ϭ 3) were snap frozen and 5-m sections were cut. The tissue sections were fixed immediately in 4% paraformaldehyde for 20 min and washed with phosphate-buffered saline (PBS) and then permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate. Each of the sample slides received 50 l of TUNEL reaction mixture and was incubated for 60 min at 37ЊC. After washing with PBS, the sections were analyzed under an Olympus fluorescent microscope. Negative control slides were performed without TUNEL mixture. Ethidium bromide (0.5 g/ml, red) in PBS was used for nuclear staining. TUNEL positive apoptotic cells were quantified per highpower field (ϫ40) and the difference to vehicle treated controls analyzed with the paired t test.
Histology
Embryonic and postnatal lungs, each from a different pregnancy (n ϭ 3) or litter, respectively, were examined histologically. Because HIF-1␣ is known to be degraded in intact cells within minutes after exposure to oxygen, embryos and lungs were immediately fixed with 4% buffered formalin (pH 7.4), processed routinely, and embedded in paraffin using an automatic tissue processor (Leica TP 1020; Leica, Heidelberg, Germany). Embedded tissues were serially sectioned at 2 m on a Micron microtome (HM 440E; Micron, Neuss, Germany) and stained with hematoxylin-eosin, Masson's trichrome, and van Gieson's elastica stain. The sections were examined using an Olympus photomicroscope.
Immunohistochemistry
Immunohistochemistry was performed on formalin-fixed, paraffinembedded tissues. Two-micrometer sections were deparaffinized with xylene and progressively rehydrated in decreasing percentages of ethanol. Antigen sites were retrieved by heating the sections on slides in 0.01 mol/liter sodium citrate in a microwave oven and cooling for 30 min to room temperature. Endogenous peroxidases were degraded by immersion of the sections in 0.3% hydrogen peroxide in methanol. Sections were blocked with blocking solution (CSA-Kit K1500; Dakocytomation, Carpenteria, CA) and incubated either with anti-HIMF antiserum (1:100; Alpha Diagnostic Int., San Antonio, TX) or anti-alkaline phosphatase antiserum (1:50; Abcam Inc., Cambridge, MA) at 4ЊC overnight or with anti-HIF-2␣ antiserum (1:1,000; Novus Biologicals) for 15 min at room temperature. The primary antibody was linked (antirabbit or anti-goat link antiserum, respectively) to a signal amplification system (CSA for HRP amplification, Envision for alkaline phosphatase amplification; Dakocytomation). Double stain block (Dakocytomation) was applied between two primary antibodies. HRP-labeled antibodies were developed with 3,3Ј-diaminobenzidine (DAB), alkaline phosphatase-labeled antibodies were developed with Fast Red.
Anti-HIF-1␣ monoclonal antiserum (1:100; Abcam Inc.) or anti-ARNT monoclonal antiserum (1:250; Abcam Inc.) were incubated for 15 min at room temperature. For visualization a signal amplification system was deployed (CSA, K1500; Dakocytomation) using DAB as chromogen.
Ex Vivo Embryonic Lung Culture
E13.5 and E16 lung cultures were prepared as described (11) . Briefly, after maternal death, sterile laparotomy was performed, and the uterus was removed with embryos intact and placed in ice-cold Hanks' balanced salt solution. Under a dissecting microscope, using microdissection forceps, the fetuses were removed from the uterus and the lungs dissected free of surrounding structures. Embryonic lungs were then placed in 50-mm culture dishes on GVWP membranes (Millipore, Bedford, MA) at the air-liquid interface in serum-free and hormone-free (BGJb) medium (Gibco BRL, Grand Island, NY) containing 0.2 mg ascorbic acid, 50 g streptomycin, and 50 units penicillin per milliliter of culture medium. The lungs were cultured for 24 h as control or with added HIMF (100 nM final concentration). Recombinant HIMF was produced as described (3) . Untreated control lungs received no additional treatment.
Results
Gene Expression in Embryonic Mouse Lung
Although we had previously reported the prominent role of HIMF in adult mouse lung (3), it was not known whether HIMF was expressed in the developing lung. Therefore, Northern blot analysis of embryonic lungs from mice E14 to P3 and of adult lung was performed ( Figure 1 ). We found a robust HIMF expression from E16 through P3 and only a low level expression at E14 and E15. Because the mouse pregnancy has a duration of 20 d, one can conclude that HIMF is upregulated in the last trimester of the pregnancy and in the perinatal period, possibly indicating an important role of HIMF in embryonic and perinatal lung maturation and lung function.
Next we wanted to elucidate the localization of the cells expressing HIMF within the lung. Using in situ hybridization we Figure 1 . Expression of HIMF mRNA in the developing lung. Fifteen micrograms of total RNA from lungs isolated and pooled from litters at E14 to adult was analyzed as described in Materials and Methods. The blot was hybridized with mouse HIMF. The lower panel shows the 28S and 18S rRNA as a control for loading. HIMF was expressed in late gestation from E16 onwards spanning into the perinatal period. In the pseudoglandular stage (E14 and E15) as well as at 4 mo (adult) HIMF expression was low. found HIMF mRNA expressed in alveolar cells ( Figures 2B, 2C , and 2G) and interstitial cells ( Figures 2D and 2E ) during the saccular and alveolar stages of lung development. In contrast, a strong expression of HIMF mRNA was noted in bronchiolar epithelial cells of adult lung (data not shown).
Expression of HIMF, HIF-1␣, and HIF-2␣ in Embryonic Lung Extracts
To show the presence of the HIMF gene product in the developing lung, a Western blot analysis was performed. HIMF expression started at E16, was readily detectable at E17 and strongly expressed through late pregnancy until the perinatal period at P3 ( Figure 3A) . No HIMF was detected at E14 or E15. Probing the lung protein extract for the presence of HIF-1␣ revealed high concentrations of HIF-1␣ at E14 but very low levels during the latter stages. In contrast, HIF-2␣ was readily detectable from E14 through E20 and postnatally until P3 ( Figure 3A ). In addition, later stages of postnatal lung development ( Figure 3B) were immunoprobed, normalized to tubulin and quantified revealing a significant (P Ͻ 0.005) upregulation of HIMF protein from throughout the saccular and alveolar stages (P1-P40, Figure 3C ).
Immunohistochemical Localization of HIMF and Coexpression with HIF-2␣
Next we were interested in demonstrating which cells express HIMF in the developing lung. A strong HIMF expression was found in the saccular stage of lung development at E18 in late gestation (Figure 4 ). Here HIMF was detected ubiquitously in the epithelial cells of conducting airways ( Figure 5A ) and in cells lining the primitive alveoli and some cells of the interalveolar mesenchyme ( Figures 5B and 5C ). Endothelial cell of the intrapulmonary vessels were stained positive for HIMF as well (data not shown). In contrast, HIMF expression could not be detected at the pseudoglandular stage (data not shown). The expression of HIMF remained at high levels until P3 (Figure 5E ), where HIMF was found in bronchiolar epithelial, alveolar epithelial, and endothelial cells. The dual immunohistochemistry depicted in Figure 5 revealed that throughout the saccular and aleolar stages HIMF was colocalized with HIF-2. At P7 the nuclear accumulation of HIF-2␣ was particularly prominent ( Figure 5F ). In the late alveolar stages HIMF-HIF-2␣ colocalization was readily detectable in bronchial epithelial cells (Figures 5H and  5K ) and in type II alveolar cells ( Figures 5I and 5J ).
Weak Expression of HIF-1␣ in the Cannalicular and Saccular Stages
To further explore the possibility of a regulatory effect of HIFs on the expression of HIMF, we investigated whether HIF-1␣, and ARNT were expressed temporally synchronized with HIMF.
In pseudoglandular lung tissue at E14 ( Figure 6A ), HIF-1␣ was detected mainly in bronchial epithelial cells. In contrast, in the canalicular ( Figure 6B ) and terminal sac ( Figures 6C and  6D ) stages of lung development HIF-1␣ was found at very low levels, incidentally suggesting that at these stages of lung development the tissue is not hypoxic. ARNT, the dimerization partner of HIF-1␣ and HIF-2␣, was expressed in all lungs investigated ( Figures 6E and 6F , and data not shown) without significant differences in signal strength between the developmental stages. Interestingly, HIF-1␣ was readily detectable in the nuclei of cardiomyocytes at E12 (Figure 6G ), which is consistent with the known importance of HIF-1␣ for the development of the cardiovascular system.
Effect of HIMF on Apoptosis in Lung Explants
During the last trimester of pregnancy, organ growth and maturation are dominant developmental processes, of which programmed cell death has been recognized to be an important feature. Therefore, the effect of HIMF on apoptosis in the developing lung was investigated in E13.5 and E16 lung explant organ cultures ( Figure 7A ). Treatment with 100 nM recombinant HIMF significantly reduced the number of TUNEL-positive, apoptotic cells (P Ͻ 0.005, Figure 7B ). These findings indicate that HIMF might play an important role in the regulation of apoptotic activities in the lung.
Discussion
The anatomic development of the lung can be regarded as a continuous process from the advent of the laryngotracheal groove until adulthood. Although recently considerable insight had been gained into budding morphogenesis and early pulmonary development (4, 12) , the regulators of normal lung development during late gestation are not known, and the mediators that interfere with lung development are not well understood (13) .
In this study we investigated the expression of HIMF in the developing mouse lung. We discovered that HIMF is present in Figure 3 . Developmental Western blot for HIMF, HIF-1␣, HIF-2␣, and ␣-tubulin 25 g of total protein from lungs isolated and pooled from different litters (n ϭ 3) were analyzed. HIMF was strongly upregulated in the saccular (A) and alveolar (C) stages of lung development. Expression of HIMF was very low at E14-E16. HIF-1␣ concentration was high in E14 lung but remained low from E15 through late gestation until P3 (A). In contrast, HIF-2␣ was readily detected in E14 to P3 lung but not in adult lung (A). Densitometric quantitation of HIMF expression normalized to ␣-tubulin (B) revealed a significant (*P Ͻ 0.005) increase of HIMF protein in the alveolar stage compared with HIMF levels in adult lung (mean Ϯ SEM, paired t test).
the developing lung and that pulmonary expression of HIMF is upregulated specifically in the saccular and alveolar stages. In the pseudoglandular stage HIMF was not found to be expressed, whereas in the saccular and alveolar stages HIMF was readily detectable and continued to be markedly upregulated until P40. Cells staining positive for HIMF were epithelial cells of the conducting airways, mesenchymal cells, and type II alveolar cells. In addition, results of dual immunohistochemistry showed that HIMF and HIF-2␣ were colocalized.
The 8-kD protein HIMF, also known as FIZZ1 (Found in Inflammatory Zone [1] ) and Relm-␣ (Resistin-Like Molecule [14] ), was originally discovered in lung and adipose tissues in mouse and human. In adult mouse lung, low-level HIMF mRNA and protein expression has been reported in bronchial epithelial cells and peribronchial stroma (15) . Upon allergic pulmonary inflammation as well as in chronic hypoxia, HIMF expression markedly increased in bronchial epithelium, type II alveolar cells, and pulmonary vasculature (1, 3) . In addition, HIMF is upregulated in macrophages in chronic type II inflammation and thus has been considered a specific marker of alternatively activated macrophages (16) .
Few data exist as to the function of HIMF. Analyzing glucose metabolism, Moore and coworkers demonstrated that HIMF expression was markedly reduced in diabetic mice, suggesting that HIMF might be involved in adipocyte homeostasis (17) . . Expression of HIF-1␣ and its dimerization partner ARNT (HIF-1␤) in the developing lung and heart. In pseudoglandular lung tissue (A ) at E14 HIF-1␣ was detected mainly in epithelial cells. But in the canalicular (B ) and terminal sac (C, D ) stages of lung development HIF-1␣ was found at very low levels, incidentally suggesting that at these developmental stages lung tissue is not hypoxic. ARNT was ubiquitously expressed in lung tissue independent of developmental stage. As an example, ARNT expression at E14 (E ) and E17 (F ) are shown. HIF-1␣ was readily detectable in the nuclei of cardiomyocytes at E12 (G ) thus highlighting the importance of HIF-1␣ for the development of the cardiovascular system. (H ) Isotype negative control. All photos at magnification ϫ200, scale 50 m.
The administration of HIMF to preadipocytes inhibited their differentiation into adipocytes (18) . Stutz and colleagues provided evidence of functional binding sites for STAT6 and CCAAT/Enhancer-binding protein (C/EBP) in the HIMF promotor (19) . We recently showed that HIMF has potent proliferative, angiogenic, and pulmonary vasoconstrictive effects (3). In rat pulmonary microvascular smooth muscle cells, AKT and phosphatidylinositol 3-kinase participate in HIMF downstream signaling. But, up till now the receptor of HIMF has remained elusive, contributing to our incomplete understanding of the HIMF signaling pathway.
Programmed cell death has an important function in the cellular remodeling of the developing lung (7), in particular during late gestation, when HIMF expression is at the highest level. Analysis of HIMF-treated lung explants revealed that HIMF significantly decreased apoptotic activity and increased lung cell density. In preterm infants, lung injury from infection or respirator therapy contributes to the development of bronchopulmonary dysplasia (20) , which is morphologically characterized by a premature arrest of alveolarization and lung development (21) . Because HIMF has potent proliferative, angiogenic, and pulmo- nary antiapoptotic properties, it is tempting to speculate that the growth-modulating properties of HIMF might overcome the developmental arrest of bronchopulmonary dysplasia.
Oxygen is an important physiologic mediator of embryonic and fetal development. In vitro studies demonstrate that proper embryonic development is dependent on physiologically low oxygen tensions (3-5%) (22) . A motif analysis of the genomic HIMF sequence revealed an HIF-binding site (HBS) in the 3Ј untranslated region. Since HIMF has been shown to be induced by hypoxia in vivo, it is reasonable to assume that the HBS in the HIMF gene is functionally responsive to HIFs (3).
HIF-1, a heterodimer composed of a regulated ␣-subunit and a constitutively expressed ␤-subunit (23), orchestrates the expression of genes contributing to the adaptation to reduced cellular oxygen availability and impaired energy state (24, 25) . HIF-1␣ expression in the embryo is primarily found in neural, mesenchymal, and vascular tissues (8, 26) . In agreement with the crucial role of HIF-1␣ for the early embryonic cardiovascular development, we found a strong HIF-1␣ expression in the heart at E12. In contrast, we observed a low expression of HIF-1␣ protein in the canalicular, saccular, and alveolar stages, thus confirming the findings of Jain and coworkers, who demonstrated low levels of HIF-1␣ mRNA in the developing lung (27) . A possible explanation could be the absence of hypoxia of the lung during embryonic development. Using the hypoxia marker pimonidazole, Lee and colleagues established that HIF-1␣ and vascular endothelial growth factor expression were spatiotemporally colocalized with hypoxic regions in embryos (28) . They observed marked hypoxia in the developing brain and heart, but they were unable to detect hypoxic regions in the lungs (28). Compernolle and associates reported a pimonidazole adductspositive signal exclusively in type II alveolar cells that was not present in directly neighboring cells (29) . Still, these findings altogether indicate that in the developing lung there is no hypoxia present sufficiently severe to induce widespread accumulation of HIF-1␣.
Recently, a second hypoxia-inducible transcription factor termed HIF-2␣ has been described (30) (31) (32) (33) . In human embryos aged 3-6 wk (34) and in the developing mouse embryo (27) , mRNA expression of the two HIFs was investigated previously, and both studies described a high expression level of HIF-2␣ mRNA in the developing lung. Of note, comparing expression levels of HIF-1␣ and HIF-2␣ in 11 human cell lines, the highest levels of HIF-2␣ mRNA have been found in fetal lung fibroblasts (35) . Our data expand this knowledge and we described for the first time the detailed pulmonary expression pattern of HIF-2␣ protein.
Compernolle and coworkers recently reported an HIF-2␣ knockout of which 50% of the HIF-2␣
Ϫ/Ϫ embryos died in utero from cardiac failure at E13.5. Of note, the remaining HIF-2␣ Ϫ/Ϫ embryos were born at term but died within 2-3 h after birth from fatal respiratory distress syndrome (29) . Though therapeutic administration of inhaled vascular endothelial growth factor to preterm mice alleviated the respiratory pathology, the putative HIF target gene HIMF might have contributed to the observed phenotype. Unfortunately, an HIMF knockout mouse model is not available at present.
In summary, we showed that HIMF is expressed in the developing lung in the saccular and alveolar stages. HIMF protein colocalizes spatially and temporally with HIF-2␣ but not HIF-1␣. While HIF-2␣ itself might play an important role in lung maturation, it is tempting to speculate that HIMF might be a downstream mediator of HIF-2␣ in embryonic lung development and maturation. The determination of the functional role of HIMF in embryonic lung warrants further investigation, ultimately contributing to a better understanding of diseases like bronchopulmonary dysplasia, characterized by a premature arrest of lung maturation.
